Blood and Bone Marrow Transplant (BMT) Clinical Trials

Blood and bone marrow transplant (BMT) clinical trials can be an outstanding treatment option for certain patients. A clinical trial is a carefully controlled research study through which the effectiveness of a newly discovered treatment is compared to that of treatments currently in widespread use.

As a core member of the BMT Clinical Trials Network, we offer an advanced program with a number of clinical trials. Oftentimes, these treatment options are available years before they are made available for widespread use.

Why should you enroll in a bone marrow transplant clinical trial?

BMT patients who participate in a clinical trial will benefit from:

  • Expertise from our multispecialty team - Our BMT and Cellular Immunotherapy Program is among the largest and most active program in the Southeast.
  • Individualized recommendations – Moffitt’s team matches each patient with the treatment opportunities that are most appropriate for their unique needs.
  • National Cancer Institute-backed studies – We are the only NCI-designated Comprehensive Cancer Center based in Florida. Many of our research studies are made possible through National Cancer Institute grants, and our Comprehensive Cancer Center designation speaks to our long-standing commitment to innovation, excellence and research.
  • Our translational approach – We use everything we learn in the laboratory to directly benefit our patients as we constantly work to determine how hematological cancer develops, spreads and responds to different treatments. Individuals who participate in our clinical trials aren’t just expanding their own options – they’re improving the future of treatment for everyone who faces a hematological cancer diagnosis.

BMT clinical trials and research at Moffitt Cancer Center

At Moffitt, we are firmly committed to taking our promising new discoveries from the research laboratory to our patients as soon as possible. In this way, we are continually improving patient outcomes and enhancing quality of life.

The decision to participate in a clinical trial is a highly personal one and participation is voluntary. Bone marrow transplant patients who participate in clinical trials at Moffitt can have peace of mind knowing that they are being closely and continually monitored by multiple experts 

If you’d like to receive information about bone marrow transplant (BMT) clinical trials that are currently accepting new patients at Moffitt, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form. We do not require referrals.

calledFromCancerPage=True - substr=
testProtocol=

Open Clinical Trials:

Showing of 50

CLINICAL TRIAL 20491

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD Following Allogeneic Hematopoietic Stem Cell Transplant

Disease Site: Graft vs Host Disease (GVHD), Unknown Sites

View Trial Details

CLINICAL TRIAL 21114

AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy

Disease Site: Graft vs Host Disease (GVHD), Unknown Sites

View Trial Details